US20100166627A1 - Use of hydrophobins as additives in the crystallization of solids - Google Patents
Use of hydrophobins as additives in the crystallization of solids Download PDFInfo
- Publication number
- US20100166627A1 US20100166627A1 US12/601,281 US60128108A US2010166627A1 US 20100166627 A1 US20100166627 A1 US 20100166627A1 US 60128108 A US60128108 A US 60128108A US 2010166627 A1 US2010166627 A1 US 2010166627A1
- Authority
- US
- United States
- Prior art keywords
- hydrophobins
- hydrophobin
- solid
- fusion
- aqueous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007787 solid Substances 0.000 title claims abstract description 42
- 238000002425 crystallisation Methods 0.000 title abstract description 16
- 230000008025 crystallization Effects 0.000 title abstract description 16
- 239000000654 additive Substances 0.000 title 1
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 26
- 239000010440 gypsum Substances 0.000 claims abstract description 26
- 239000008346 aqueous phase Substances 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims description 43
- 230000004927 fusion Effects 0.000 claims description 42
- 101710091977 Hydrophobin Proteins 0.000 claims description 32
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 8
- 239000003546 flue gas Substances 0.000 claims description 8
- 239000007791 liquid phase Substances 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 238000006477 desulfuration reaction Methods 0.000 claims description 6
- 230000023556 desulfurization Effects 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- 235000018417 cysteine Nutrition 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000003776 cleavage reaction Methods 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 230000007017 scission Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 101710195795 Hydrophobin-B Proteins 0.000 description 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 150000001945 cysteines Chemical class 0.000 description 5
- 238000010353 genetic engineering Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 101710195603 Hydrophobin A Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 229910052925 anhydrite Inorganic materials 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 210000003000 inclusion body Anatomy 0.000 description 4
- 235000006109 methionine Nutrition 0.000 description 4
- 150000007523 nucleic acids Chemical group 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 235000004400 serine Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000008521 threonine Nutrition 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 101100215658 Aspergillus parasiticus (strain ATCC 56775 / NRRL 5862 / SRRC 143 / SU-1) aflY gene Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101100232322 Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) hypA2 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101100059802 Chlamydophila caviae (strain ATCC VR-813 / DSM 19441 / GPIC) groEL1 gene Proteins 0.000 description 1
- 101100365080 Clostridium perfringens (strain 13 / Type A) scpB gene Proteins 0.000 description 1
- 101100387133 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) dewA gene Proteins 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000222481 Schizophyllum commune Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101100232321 Synechocystis sp. (strain PCC 6803 / Kazusa) hypA1 gene Proteins 0.000 description 1
- 241000228341 Talaromyces Species 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001295 alanines Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010261 calcium sulphite Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 101150077981 groEL gene Proteins 0.000 description 1
- 101150006844 groES gene Proteins 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 101150081485 hypA gene Proteins 0.000 description 1
- 101150019385 hypB gene Proteins 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 150000002742 methionines Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 101150001852 mrdB gene Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006259 organic additive Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 101150042737 rodA gene Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 150000003588 threonines Chemical class 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
- C01F11/46—Sulfates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/34—Chemical or biological purification of waste gases
- B01D53/46—Removing components of defined structure
- B01D53/48—Sulfur compounds
- B01D53/50—Sulfur oxides
- B01D53/507—Sulfur oxides by treating the gases with other liquids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
- C01F11/18—Carbonates
- C01F11/182—Preparation of calcium carbonate by carbonation of aqueous solutions and characterised by an additive other than CaCO3-seeds
- C01F11/183—Preparation of calcium carbonate by carbonation of aqueous solutions and characterised by an additive other than CaCO3-seeds the additive being an organic compound
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
- C01F11/46—Sulfates
- C01F11/466—Conversion of one form of calcium sulfate to another
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/02—Particle morphology depicted by an image obtained by optical microscopy
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/30—Particle morphology extending in three dimensions
- C01P2004/40—Particle morphology extending in three dimensions prism-like
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/54—Particles characterised by their aspect ratio, i.e. the ratio of sizes in the longest to the shortest dimension
Definitions
- the present invention concerns to the use of hydrophobins as auxiliaries in the crystallization of solids, in particular the use for producing gypsum from an aqueous phase.
- the properties of finely divided solids are very substantially determined by the size and habit of the crystallites making up the solid. Size and habit substantially influence the rheological properties of solid suspensions, the ease of removal of the solids from aqueous suspensions, for example by filtration, the handling of the dried products and the properties of the solids themselves.
- An example is the color strength or the dispersibility of color pigments, which substantially depend on the size and habit of the individual crystals.
- Hydrophobins are small proteins of about 100 to 150 amino acids that occur in filamentous fungi, for example Schizophyllum commune . They generally have 8 cysteine units. Hydrophobins can be isolated from natural sources, but they can also be obtained by means of genetic-engineering processes as disclosed for example by
- WO 96/41882 proposes the use of hydrophobins as emulgators, thickeners or surfactants, for giving hydrophilic properties to hydrophobic surfaces, for improving water-resistance of hydrophilic substrates, for preparing oil-in-water emulsions or water-in-oil emulsions. Further proposals include pharmaceutical applications such as the preparation of ointments or creams and also cosmetic applications such as skin protection or the production of shampoos or conditioners.
- EP 1 252 516 discloses the coating of various substrates with a hydrophobin-containing solution at a temperature of 30 to 80° C.
- hydrophobins as crystallization auxiliaries
- a further embodiment of the present invention is a process for producing a solid by crystallizing from an aqueous phase and separating the solid formed from the aqueous phase wherein said aqueous phase has added to it, in an amount of 0.001% to 1% by weight based on the total amount of said aqueous phase, at least one auxiliary soluble in said aqueous phase, at least one of said auxiliaries comprising a hydrophobin.
- the process in question is a process for producing gypsum. It is particularly preferable for the process in question to be a step in a flue gas desulfurization process.
- hydrophobins as used herein shall hereinbelow refer to polypeptides of the general structural formula (I)
- X may be any of the 20 naturally occurring amino acids (Phe, Leu, Ser, Tyr, Cys, Trp, Pro, His, Gln, Arg, Ile, Met, Thr, Asn, Lys, Val, Ala, Asp, Glu, Gly).
- Each X may be the same or different.
- the indices next to X indicate in each case the number of amino acids, C represents cysteine, alanine, serine, glycine, methionine or threonine subject to the proviso that at least four of the residues identified by C are cysteine, and the indices n and m are independently natural numbers in the range from 0 to 500 and preferably in the range from 15 to 300.
- the polypeptides of formula (I) are further characterized by the property (after coating of a glass surface) of increasing the contact angle of a drop of water by at least 20°, preferably at least 25° and more preferably at least 30°, compared with the contact angle formed by a drop of water of the same size with the uncoated glass surface, each measurement being carried out at room temperature.
- the amino acids denoted C 1 to C 8 are preferably cysteines; but they may also be replaced by other amino acids of similar bulk, preferably by alanine, serine, threonine, methionine or glycine. However, at least four, preferably at least 5, more preferably at least 6 and especially at least 7 of the C 1 to C 8 positions shall consist of cysteines. Cysteines in proteins used according to the present invention may be present in reduced form or form disulfide bridges with one another. Particular preference is given to intramolecular formation of C-C bridges, in particular that involving at least one, preferably 2, more preferably 3 and most preferably 4 intramolecular disulfide bridges. In the case of the above-described exchange of cysteines for amino acids of similar bulk, it is advantageous for such C-positions to be involved in a pairwise exchange as are able to form intramolecular disulfide bridges with each other.
- cysteines When cysteines, serines, alanines, glycines, methionines or threonines are used in the positions designated X, the numbering of the individual C-positions in the general formulae may change accordingly.
- the indices n and m represent numbers in the range from 0 to 350 and preferably from 15 to 300, and the proteins are further distinguished by the abovementioned contact angle change, and at least 6 of the residues denoted C comprise cysteine. It is particularly preferable for all the C residues to comprise cysteine.
- the proteins are further distinguished by the abovementioned contact angle change and furthermore at least six of the residues denoted C are cysteine. It is particularly preferable for all residues denoted C to be cysteine.
- residues X n and X m may be peptide sequences which may be naturally linked to a hydrophobin. However, either or both of the residues X n and X. may be peptide sequences which are not naturally linked to a hydrophobin. This also includes X m , and/or X m residues in which a peptide sequence naturally occurring in a hydrophobin is extended by a peptide sequence not naturally occurring in a hydrophobin.
- X n and/or X m are peptide sequences which are not naturally linked to hydrophobins
- the length of such sequences is generally at least 20 amino acids, preferably at least 35 amino acids. These may be sequences of from 20 to 500, preferably 30 to 400 and particularly preferably 35 to 100 amino acids, for example.
- a residue of this kind, which is not naturally linked to a hydrophobin will also be referred to as a fusion partner hereinbelow. This is intended to articulate the fact that the proteins consist of at least one hydrophobin portion and a fusion partner portion which do not occur together in this form in nature. Fusion hydrophobins composed of a fusion partner and a hydrophobin portion are disclosed for example in WO 2006/082251, WO 2006/082253 and WO 2006/131564.
- the fusion partner portion may be selected from a multiplicity of proteins. It is possible for only one fusion partner to be linked to the hydrophobin portion or it is only possible for a plurality of fusion partners to be linked to one hydrophobin portion, for example to the amino terminus (X n .) and to the carboxy terminus (X m ) of the hydrophobin portion. But it is also possible, for example, to link two fusion partners to one position (X n or X m ) of the protein according to the present invention.
- fusion partners are proteins which occur naturally in microorganisms, in particular in E. coli or Bacillus subtilis .
- fusion partners are the sequences yaad (SEQ ID NO: 16 in WO 2006/082251), yaae (SEQ ID NO: 18 in WO 2006/082251) and thioredoxin.
- fragments or derivatives of the aforementioned sequences which comprise only a portion, for example 70% to 99%, preferably 5% to 50% and more preferably 10% to 40%, of said sequences, or in which individual amino acids or nucleotides have been altered compared with the sequence mentioned, the percentages each being based on the number of amino acids.
- the fusion hydrophobin has not only the fusion partner mentioned but also, as one of the groups X n or X m or as a terminal constituent of such a group, an “affinity domain” in the form of an affinity tag/tail.
- Affinity tags or tails comprise anchor groups which can interact with certain complementary groups and can serve to facilitate workup and purification of the proteins. Examples of such affinity domains comprise (His) k , (Arg) k , (Asp) k , (Phe) k or (Cys) k groups, where k is generally a natural number from 1 to 10.
- a (His) k group may be preferable, in which case k is from 4 to 6.
- the X n and/or X m group may consist exclusively of such an affinity domain, or else an X n or X m residue which is naturally linked or not naturally linked to a hydrophobin is extended by a terminally disposed affinity domain.
- proteins used according to the present invention as hydrophobins or derivatives thereof may additionally be modified in their polypeptide sequence, for example by glycosilation, acetylation or else by chemical crosslinking, for example with glutaraldehyde.
- One property of the hydrophobins used according to the present invention, or of their derivatives, is the change in surface properties when the surfaces are coated with the proteins.
- the change in surface properties can be determined experimentally, for example, by measuring the contact angle of a drop of water before and after coating of the surface with the protein and determining the difference between the two measurements.
- the fusion proteins used according to the present invention have the property of increasing the contact angle by at least 20°, preferably at least 25° and particularly preferably at least 30° in each case compared with the contact angle of an identically sized water droplet with the uncoated glass surface.
- hydrophobins for embodying the present invention are the hydrophobins of the type dewA, rodA, hypA, hypB, sc3, basf1, basf2. These hydrophobins including their sequences are disclosed for example in WO 2006/82251. Unless otherwise stated, the sequences referred to hereinbelow relate to the sequences disclosed in WO 2006/82251. An overview table featuring the SEQ-ID numbers is to be found in WO 2006/82251 at page 20.
- fusion proteins yaad-Xa-dewA-his (SEQ ID NO: 20), yaad-Xa-rodA-his (SEQ ID NO: 22) or yaad-Xa-basfl-his (SEQ ID NO: 24) having the polypeptide sequences placed between parentheses and also the nucleic acid sequences which code therefor, especially the sequences according to SEQ ID NO: 19, 21, 23. It may be particularly preferable to use yaad-Xa-dewA-his (SEQ ID NO: 20). Similarly, proteins which, proceeding from the polypeptide sequences shown in SEQ ID NO.
- a biological property of the proteins is herein to be understood as meaning the already described change in the contact angle by at least 20°.
- Derivatives particularly suitable for embodying the present invention are derivatives derived from yaad-Xa-dewA-his (SEQ ID NO: 20), yaad-Xa-rodA-his (SEQ ID NO: 22) or yaad-Xa-basfl-his (SEQ ID NO: 24) by truncating the yaad fusion partner.
- the complete yaad fusion partner SEQ ID NO: 16
- the truncated residue should comprise at least 20, preferably at least 35 amino acids.
- a truncated residue having 20 to 293, preferably 25 to 250, more preferably 35 to 150 and for example 35 to 100 amino acids can be used.
- a protein is yaad40-Xa-dewA-his (SEQ ID NO: 26 in PCT/EP2006/064720), which has a yaad residue truncated to 40 amino acids.
- a cleavage site between the hydrophobin and the fusion partner or partners can be utilized to detach the fusion partner and to release the pure hydrophobin in underivatized form (for example by BrCN cleavage at methionine, factor Xa cleavage, enterokinase cleavage, thrombin cleavage, TEV cleavage, etc).
- hydrophobins used according to the present invention as a crystallization auxiliary can be prepared chemically by known methods of peptide synthesis, for example by Merrifield solid-phase synthesis.
- Naturally occurring hydrophobins can be isolated from natural sources by means of suitable methods. Reference may be made by way of example to Wösten et al., Eur. J Cell Bio. 63, 122-129 (1994) or WO 96/41882.
- Fusion proteins may preferably be prepared by genetic-engineering processes wherein a nucleic acid sequence coding for the fusion partner and a nucleic acid sequence coding for the hydrophobin portion, in particular a DNA sequence, are combined such that the desired protein is generated in a host organism as a result of gene expression of the combined nucleic acid sequence.
- a production process is disclosed for example by WO 2006/082251 or WO 2006/082253.
- the fusion partners greatly facilitate the production of the hydrophobins. Fusion hydrophobins are produced in the genetic-engineering processes in distinctly better yields than hydrophobins without fusion partners.
- the fusion hydrophobins produced by the genetic engineering method from the host organisms can be worked up in a manner known in principle and be purified by means of known chromatographic methods.
- One preferred embodiment may utilize the simplified workup and purification process disclosed in WO 2006/082253 at pages 11/12.
- the fermented cells are initially separated from the fermentation broth, disrupted and the cell debris separated from the inclusion bodies.
- the latter may advantageously be done by centrifugation.
- the inclusion bodies can be disrupted in a manner known in principle, for example by means of acids, bases and/or detergents, to release the fusion hydrophobins.
- the inclusion bodies with the fusion hydrophobins used according to the present invention can generally be completely dissolved within about 1 h even when using 0.1 M NaOH.
- the solutions obtained can be used without further purification to embody this invention.
- the fusion hydrophobins can also be isolated from the solutions as a solid. It may be preferable to isolate by means of spray drying, as described in WO 2006/082253 at page 12.
- the products obtained by the simplified workup and purification process generally comprise about 80% to 90% by weight of proteins as well as remnants of cell debris.
- the amount in terms of fusion hydrophobins generally ranges from 30% to 80% by weight, based on the amount of all the proteins, depending on the fusion construct and the fermentation conditions.
- the isolated products comprising fusion hydrophobins can be stored as solids and for use be dissolved in the particular desired media.
- the fusion hydrophobins can be used as such or also after cleavage and removal of the fusion partner as “pure” hydrophobins for carrying out this invention.
- a cleavage is undertaken advantageously following isolation of the inclusion bodies and their dissolution.
- the hydrophobins are used as auxiliaries in the crystallization of solids by effecting the crystallization in the presence of hydrophobins.
- One preferred embodiment of the present invention comprises a crystallization of solids from liquid phases.
- the liquid phases comprise one or more solvents, dissolved solid and/or starting materials for their production, the hydrophobins and also optionally further components, for example further auxiliary materials.
- the choice of solvent or solvent mixture is not restricted in principle, provided the solids to be crystallized and the hydrophobins have sufficient solubility therein. A person skilled in the art will make suitable choice depending on the solid to be crystallized.
- the liquid phases preferably comprise aqueous phases.
- aqueous phase is to be understood as meaning that the solvents used comprise at least 50% by weight of water, based on the total amount of all solvents used.
- the water content is preferably at least 70% by weight and more preferably at least 90% by weight.
- Possible cosolvents include water-miscible solvents, for example alcohols such as methanol, ethanol or propanol. It is very particularly preferred for the solvent to comprise exclusively water.
- the pH of the aqueous phase can be chosen by one skilled in the art according to the identity of the solid to be crystallized and according to the properties desired for the solid.
- the hydrophobins preferably fusion hydrophobins can advantageously be used at a pH ⁇ 4, in particular 4 to 13.
- the pH range is preferably from 5 to 13, more preferably from 6 to 12 and most preferably from 7 to 11.
- the amount of the hydrophobins to be used can be chosen by one skilled in the art according to the identity of the solid to be crystallized and according to the properties desired for the solid. In general an amount of less than 1% by weight based on the sum total of all the constituents of the aqueous phase will be found advantageous.
- the hydrophobins may preferably be used in an amount of 0.001% by weight to 1% by weight, more preferably 0.001% to 0.2% by weight.
- yaad-Xa-dewA-his SEQ ID NO: 20
- proteins having a truncated yaad residue for example yaad40-Xa-dewA-his. It is advantageous to use the products obtained by the simplified purification process described above.
- the hydrophobins are useful as auxiliaries for crystallizing both inorganic and organic solids from liquid phases.
- the hydrophobins are particularly useful as auxiliaries for crystallizing gypsum (CaSO4*2H2O). instead of acicular crystallites, more compact crystallites having a distinctly smaller length/thickness ratio are obtained which are easier to separate from the aqueous phase.
- the hydrophobins are further very useful for crystallizing calcium carbonate.
- the hydrophobins can be used in a process for producing solids by crystallizing from an aqueous phase and removing the solid formed from the aqueous phase.
- the process in question may particularly preferably be a process for removal of gypsum.
- the step of crystallizing and preferred conditions were described above.
- the solids preferably the gypsum, can be removed by methods known to one skilled in the art, for example by filtration or by a combination of various measures to separate liquids from solids. After separation, the moist solid can be dried and further processed.
- the process of the present invention may particularly comprise a step of a flue gas desulfurization process.
- a first stage comprises gaseous SO 2 present in the flue gas being reacted in a washers known to one skilled in the art with an aqueous CaCO 3 suspension to form CaSO3 which is oxidized with O 2 to form CaSO 4 , which crystallizes out as CaSO 4 *2H2O.
- CaSO3 which is oxidized with O 2 to form CaSO 4
- CaSO 4 which crystallizes out as CaSO 4 *2H2O.
- gypsum is formed continuously in the aqueous phase by reaction.
- the hydrophobins are added to the process water in the above-stated concentrations.
- Flue gas desulfurization processes are known to those skilled in the art.
- the reaction of SO 2 and CaCO 3 may be carried out coutercurrently for example.
- the gypsum crystals formed can initially be separated off, as a concentrated gypsum suspension, in a hydrocyclone and then be recovered as a solid by filtration, washing and drying.
- FOG Flue Gas Desulphokation
- hydrophobin A a fusion hydrophobin with the complete fusion partner yaad (yaad-Xa-dewA-his; hereinafter referred to as hydrophobin A) and also a fusion hydrophobin having a fusion partner truncated to 40 amino acids, yaad40-Xa-dewA-his (hydrophobin B).
- hydrophobin A a fusion hydrophobin with the complete fusion partner yaad
- hydrophobin B a fusion hydrophobin having a fusion partner truncated to 40 amino acids
- Example 9 of WO 2006/82253 The products were worked up by the simplified purification process of Example 9 of WO 2006/82253 and spray dried according to Example 10 of the same reference.
- the total protein content of the dried products obtained was in each case about 70% to 95% by weight, and the hydrophobin content was about 40% to 90% by weight based on the total protein content.
- the products were used as such for the experiments.
- the spray-dried products comprising fusion hydrophobins were dissolved in water in the presence of 50 mm sodium acetate pH 4 and 0.1% by weight of polyoxyethylene(20) sorbitan monolaurate (Tween® 20). Concentration of product: 100 ⁇ g/mL in aqueous solution.
- the samples are air dried and subjected at room temperature to a determination of the contact angle (in degrees) of a droplet of 5 ⁇ l of water.
- the contact angle measurement was determined on a Dataphysics Contact Angle System OCA 15+, Software SCA 20.2.0. (November 2002). The measurement was carried out in accordance with the manufacturer's instructions.
- Untreated glass gave a contact angle of 15° to 30° ⁇ 5°.
- a coating with the fusion hydrophobin yaad-Xa-dewA-his 6 gave a contact angle increase of more than 30°; a coating with the fusion hydrophobin yaad40-Xa-dewA-his likewise gave a contact angle increase of more then 30°.
- a saturated solution of CaSO 4 ⁇ 2 H 2 in completely ion-free water was prepared (concentration about 2 g/l).
- the solutions were each admixed with hydrophobin A and hydrophobin B respectively, so that the gypsum solution had a concentration of about 0.1 g/l of the spray-dried product.
- the pH of the solution was adjusted with HCl and NaOH respectively.
- the aqueous solutions/dispersions were filtered through a pleated filter (about 10 ⁇ m). Thereafter, about 25 ml of each solution were transferred into a Petri dish and the water was allowed to evaporate at room temperature in the course of about 24 hours. A solution was left for comparison without added hydrophobin.
- FIGS. 1 to 6 each show micrographs of the crystals obtained (40 fold magnification, particle size in each case about 0.01-0.1 mm).
- FIG. 1 pH 8, no addition of hydrophobin
- FIG. 2 pH 8, addition of hydrophobin A
- FIG. 3 pH 8, addition of hydrophobin B
- FIG. 4 pH 4, addition of hydrophobin B
- FIG. 5 pH 6, addition of hydrophobin B
- FIG. 6 pH 10, addition of hydrophobin B
- FIGS. 1 to 6 show that the crystal form of gypsum can be influenced via hydrophobins.
- Gypsum precipitated at pH 8 without auxiliary consists of needles having a length/thickness ratio of about 10 ( FIG. 1 ).
- Gypsum precipitated at a pH of 8 with addition of hydrophobin A ( FIG. 2 ) or hydrophobin B ( FIG. 3 ) no longer consists of needles; instead, relatively compact prisms having a length/thickness ratio of about 2 to 3 are obtained.
- the needle length is distinctly truncated compared with the test without added hydrophobin. Such compact particles have better filtration properties.
- the needle length is truncated by the hydrophobins at all pH values ( FIGS. 4 to 6 ). This effect is most pronounced in the alkaline pH region ( FIGS. 1 to 3 and 6 ), in which prisms are obtained almost exclusively and no longer any needles.
Abstract
Use of hydrophobins as auxiliaries in the crystallization of solids, in particular the use for producing gypsum from an aqueous phase.
Description
- The present invention concerns to the use of hydrophobins as auxiliaries in the crystallization of solids, in particular the use for producing gypsum from an aqueous phase.
- The properties of finely divided solids are very substantially determined by the size and habit of the crystallites making up the solid. Size and habit substantially influence the rheological properties of solid suspensions, the ease of removal of the solids from aqueous suspensions, for example by filtration, the handling of the dried products and the properties of the solids themselves. An example is the color strength or the dispersibility of color pigments, which substantially depend on the size and habit of the individual crystals.
- It is known in principle to use suitable inorganic or organic additives to influence the size and habit of the crystallites forming in the course of precipitation or crystallization from solutions. Reference may be made here for example to “Crystallization and Precipitation—4.4 Crystal Habit Modification” in Ullmann's Encyclopedia of Industrial Chemistry, 7th Edition 2006, Electronic Release, Wiley-VCH, Weinheim, New York 2006.
- Influencing the size and habit of the crystallites of gypsum is a much studied process (see for example G. A. Bertoldi, Zement-Kalk-Gips, Nr. 12, 1978). Aqueous suspensions of gypsum are these days generated in large volumes in flue gas desulfurization. For further use, the gypsum has to be separated from the aqueous phase. Gypsum typically crystallizes in the form of needles. U.S. Pat. No. 4,183,908 and U.S. Pat. No. 5,246,677 discloses processes for crystallizing gypsum in the form of compact crystals by addition of polyphosphates, organic phosphates or phosphonates to facilitate the removal of the gypsum from the aqueous phase.
- Hydrophobins are small proteins of about 100 to 150 amino acids that occur in filamentous fungi, for example Schizophyllum commune. They generally have 8 cysteine units. Hydrophobins can be isolated from natural sources, but they can also be obtained by means of genetic-engineering processes as disclosed for example by
- There is a prior art proposing the use of hydrophobins for various applications.
- WO 96/41882 proposes the use of hydrophobins as emulgators, thickeners or surfactants, for giving hydrophilic properties to hydrophobic surfaces, for improving water-resistance of hydrophilic substrates, for preparing oil-in-water emulsions or water-in-oil emulsions. Further proposals include pharmaceutical applications such as the preparation of ointments or creams and also cosmetic applications such as skin protection or the production of shampoos or conditioners.
- EP 1 252 516 discloses the coating of various substrates with a hydrophobin-containing solution at a temperature of 30 to 80° C.
- Further proposals include for example the use as a demulsifier (WO 2006/103251), as an evaporation retarder (WO 2006/128877) or as a soil inhibitor (WO 2006/103215).
- The use of hydrophobins as crystallization auxiliaries has hitherto not been disclosed.
- It is an object of the present invention to provide novel auxiliaries for influencing the crystallization.
- We have found that this object is achieved by the use of hydrophobins as auxiliaries in the crystallization of solids.
- A further embodiment of the present invention is a process for producing a solid by crystallizing from an aqueous phase and separating the solid formed from the aqueous phase wherein said aqueous phase has added to it, in an amount of 0.001% to 1% by weight based on the total amount of said aqueous phase, at least one auxiliary soluble in said aqueous phase, at least one of said auxiliaries comprising a hydrophobin.
- In one preferred embodiment of the present invention, the process in question is a process for producing gypsum. It is particularly preferable for the process in question to be a step in a flue gas desulfurization process.
- A detailed description of the present invention follows:
- The term “hydrophobins” as used herein shall hereinbelow refer to polypeptides of the general structural formula (I)
-
Xn—C1—X1-50—C2—X0-5—C3—X1-100—C4—X1-100—C5—X1-50—C6—X0-5—C7—X1-50—C8—Xm (I) - where X may be any of the 20 naturally occurring amino acids (Phe, Leu, Ser, Tyr, Cys, Trp, Pro, His, Gln, Arg, Ile, Met, Thr, Asn, Lys, Val, Ala, Asp, Glu, Gly). Each X may be the same or different. The indices next to X indicate in each case the number of amino acids, C represents cysteine, alanine, serine, glycine, methionine or threonine subject to the proviso that at least four of the residues identified by C are cysteine, and the indices n and m are independently natural numbers in the range from 0 to 500 and preferably in the range from 15 to 300.
- The polypeptides of formula (I) are further characterized by the property (after coating of a glass surface) of increasing the contact angle of a drop of water by at least 20°, preferably at least 25° and more preferably at least 30°, compared with the contact angle formed by a drop of water of the same size with the uncoated glass surface, each measurement being carried out at room temperature.
- The amino acids denoted C1 to C8 are preferably cysteines; but they may also be replaced by other amino acids of similar bulk, preferably by alanine, serine, threonine, methionine or glycine. However, at least four, preferably at least 5, more preferably at least 6 and especially at least 7 of the C1 to C8 positions shall consist of cysteines. Cysteines in proteins used according to the present invention may be present in reduced form or form disulfide bridges with one another. Particular preference is given to intramolecular formation of C-C bridges, in particular that involving at least one, preferably 2, more preferably 3 and most preferably 4 intramolecular disulfide bridges. In the case of the above-described exchange of cysteines for amino acids of similar bulk, it is advantageous for such C-positions to be involved in a pairwise exchange as are able to form intramolecular disulfide bridges with each other.
- When cysteines, serines, alanines, glycines, methionines or threonines are used in the positions designated X, the numbering of the individual C-positions in the general formulae may change accordingly.
- Preference for embodying the present invention is given to using hydrophobins of the general formula (II)
-
Xn—C1—X3-25—C2—X5-50—C4—X2-35—C5—X2-15—C8—X0-2—C7—X3-35—C8—Xm (II) - where X, C and the indices next to X and C are each as defined above, the indices n and m represent numbers in the range from 0 to 350 and preferably from 15 to 300, and the proteins are further distinguished by the abovementioned contact angle change, and at least 6 of the residues denoted C comprise cysteine. It is particularly preferable for all the C residues to comprise cysteine.
- Particular preference is given to using hydrophobins of the general formula (III)
-
Xn—C1—X5-9—C2—C3—X11-39—C4—X2-23—C8—X5-9—C6—C7—X6-18—C8—Xm (III) - where X, C and the indices next to X are each as defined above, the indices n and m represent numbers in the range from 0 to 200, the proteins are further distinguished by the abovementioned contact angle change and furthermore at least six of the residues denoted C are cysteine. It is particularly preferable for all residues denoted C to be cysteine.
- The residues Xn and Xm may be peptide sequences which may be naturally linked to a hydrophobin. However, either or both of the residues Xn and X. may be peptide sequences which are not naturally linked to a hydrophobin. This also includes Xm, and/or Xm residues in which a peptide sequence naturally occurring in a hydrophobin is extended by a peptide sequence not naturally occurring in a hydrophobin.
- When Xn and/or Xm are peptide sequences which are not naturally linked to hydrophobins, the length of such sequences is generally at least 20 amino acids, preferably at least 35 amino acids. These may be sequences of from 20 to 500, preferably 30 to 400 and particularly preferably 35 to 100 amino acids, for example. A residue of this kind, which is not naturally linked to a hydrophobin, will also be referred to as a fusion partner hereinbelow. This is intended to articulate the fact that the proteins consist of at least one hydrophobin portion and a fusion partner portion which do not occur together in this form in nature. Fusion hydrophobins composed of a fusion partner and a hydrophobin portion are disclosed for example in WO 2006/082251, WO 2006/082253 and WO 2006/131564.
- The fusion partner portion may be selected from a multiplicity of proteins. It is possible for only one fusion partner to be linked to the hydrophobin portion or it is only possible for a plurality of fusion partners to be linked to one hydrophobin portion, for example to the amino terminus (Xn.) and to the carboxy terminus (Xm) of the hydrophobin portion. But it is also possible, for example, to link two fusion partners to one position (Xn or Xm) of the protein according to the present invention.
- Particularly suitable fusion partners are proteins which occur naturally in microorganisms, in particular in E. coli or Bacillus subtilis. Examples of such fusion partners are the sequences yaad (SEQ ID NO: 16 in WO 2006/082251), yaae (SEQ ID NO: 18 in WO 2006/082251) and thioredoxin. Also highly suitable are fragments or derivatives of the aforementioned sequences which comprise only a portion, for example 70% to 99%, preferably 5% to 50% and more preferably 10% to 40%, of said sequences, or in which individual amino acids or nucleotides have been altered compared with the sequence mentioned, the percentages each being based on the number of amino acids.
- In a further preferred embodiment, the fusion hydrophobin has not only the fusion partner mentioned but also, as one of the groups Xn or Xmor as a terminal constituent of such a group, an “affinity domain” in the form of an affinity tag/tail. Affinity tags or tails, as will be known in principle, comprise anchor groups which can interact with certain complementary groups and can serve to facilitate workup and purification of the proteins. Examples of such affinity domains comprise (His)k, (Arg)k, (Asp)k, (Phe)k or (Cys)k groups, where k is generally a natural number from 1 to 10. A (His)k group may be preferable, in which case k is from 4 to 6. The Xn and/or Xm group may consist exclusively of such an affinity domain, or else an Xn or Xm residue which is naturally linked or not naturally linked to a hydrophobin is extended by a terminally disposed affinity domain.
- The proteins used according to the present invention as hydrophobins or derivatives thereof may additionally be modified in their polypeptide sequence, for example by glycosilation, acetylation or else by chemical crosslinking, for example with glutaraldehyde.
- One property of the hydrophobins used according to the present invention, or of their derivatives, is the change in surface properties when the surfaces are coated with the proteins. The change in surface properties can be determined experimentally, for example, by measuring the contact angle of a drop of water before and after coating of the surface with the protein and determining the difference between the two measurements.
- A person skilled in the art will know in principle how to perform contact angle measurements. The measurements relate to room temperature and water droplets of 5 I and the use of glass plates as substrate. The precise experimental conditions for a method suitable by way of example measuring the contact angle are described in the experimental portion. Under the conditions mentioned there, the fusion proteins used according to the present invention have the property of increasing the contact angle by at least 20°, preferably at least 25° and particularly preferably at least 30° in each case compared with the contact angle of an identically sized water droplet with the uncoated glass surface.
- Particularly preferred hydrophobins for embodying the present invention are the hydrophobins of the type dewA, rodA, hypA, hypB, sc3, basf1, basf2. These hydrophobins including their sequences are disclosed for example in WO 2006/82251. Unless otherwise stated, the sequences referred to hereinbelow relate to the sequences disclosed in WO 2006/82251. An overview table featuring the SEQ-ID numbers is to be found in WO 2006/82251 at page 20.
- Particularly suitable according to the present invention are the fusion proteins yaad-Xa-dewA-his (SEQ ID NO: 20), yaad-Xa-rodA-his (SEQ ID NO: 22) or yaad-Xa-basfl-his (SEQ ID NO: 24) having the polypeptide sequences placed between parentheses and also the nucleic acid sequences which code therefor, especially the sequences according to SEQ ID NO: 19, 21, 23. It may be particularly preferable to use yaad-Xa-dewA-his (SEQ ID NO: 20). Similarly, proteins which, proceeding from the polypeptide sequences shown in SEQ ID NO. 20, 22 or 24, result through exchange, insertion or deletion of at least one, up to 10, preferably 5 and more preferably 5% of all amino acids and which still have the biological property of the starting proteins to an extent of at least 50% are particularly preferred embodiments. A biological property of the proteins is herein to be understood as meaning the already described change in the contact angle by at least 20°.
- Derivatives particularly suitable for embodying the present invention are derivatives derived from yaad-Xa-dewA-his (SEQ ID NO: 20), yaad-Xa-rodA-his (SEQ ID NO: 22) or yaad-Xa-basfl-his (SEQ ID NO: 24) by truncating the yaad fusion partner. Instead of the complete yaad fusion partner (SEQ ID NO: 16) having 294 amino acids, it may be advantageous to use a truncated yaad residue. However, the truncated residue should comprise at least 20, preferably at least 35 amino acids. For example, a truncated residue having 20 to 293, preferably 25 to 250, more preferably 35 to 150 and for example 35 to 100 amino acids can be used. One example of such a protein is yaad40-Xa-dewA-his (SEQ ID NO: 26 in PCT/EP2006/064720), which has a yaad residue truncated to 40 amino acids.
- A cleavage site between the hydrophobin and the fusion partner or partners can be utilized to detach the fusion partner and to release the pure hydrophobin in underivatized form (for example by BrCN cleavage at methionine, factor Xa cleavage, enterokinase cleavage, thrombin cleavage, TEV cleavage, etc).
- The hydrophobins used according to the present invention as a crystallization auxiliary can be prepared chemically by known methods of peptide synthesis, for example by Merrifield solid-phase synthesis.
- Naturally occurring hydrophobins can be isolated from natural sources by means of suitable methods. Reference may be made by way of example to Wösten et al., Eur. J Cell Bio. 63, 122-129 (1994) or WO 96/41882.
- A genetic-engineering production process for hydrophobins without fusion partners from Talaromyces thermophllus is described by US 2006/0040349.
- Fusion proteins may preferably be prepared by genetic-engineering processes wherein a nucleic acid sequence coding for the fusion partner and a nucleic acid sequence coding for the hydrophobin portion, in particular a DNA sequence, are combined such that the desired protein is generated in a host organism as a result of gene expression of the combined nucleic acid sequence. Such a production process is disclosed for example by WO 2006/082251 or WO 2006/082253. The fusion partners greatly facilitate the production of the hydrophobins. Fusion hydrophobins are produced in the genetic-engineering processes in distinctly better yields than hydrophobins without fusion partners.
- The fusion hydrophobins produced by the genetic engineering method from the host organisms can be worked up in a manner known in principle and be purified by means of known chromatographic methods.
- One preferred embodiment may utilize the simplified workup and purification process disclosed in WO 2006/082253 at pages 11/12. To this end, the fermented cells are initially separated from the fermentation broth, disrupted and the cell debris separated from the inclusion bodies. The latter may advantageously be done by centrifugation. Finally, the inclusion bodies can be disrupted in a manner known in principle, for example by means of acids, bases and/or detergents, to release the fusion hydrophobins. The inclusion bodies with the fusion hydrophobins used according to the present invention can generally be completely dissolved within about 1 h even when using 0.1 M NaOH.
- The solutions obtained can be used without further purification to embody this invention. The fusion hydrophobins, however, can also be isolated from the solutions as a solid. It may be preferable to isolate by means of spray drying, as described in WO 2006/082253 at page 12. The products obtained by the simplified workup and purification process generally comprise about 80% to 90% by weight of proteins as well as remnants of cell debris. The amount in terms of fusion hydrophobins generally ranges from 30% to 80% by weight, based on the amount of all the proteins, depending on the fusion construct and the fermentation conditions.
- The isolated products comprising fusion hydrophobins can be stored as solids and for use be dissolved in the particular desired media.
- The fusion hydrophobins can be used as such or also after cleavage and removal of the fusion partner as “pure” hydrophobins for carrying out this invention. A cleavage is undertaken advantageously following isolation of the inclusion bodies and their dissolution.
- In accordance with the present invention, the hydrophobins are used as auxiliaries in the crystallization of solids by effecting the crystallization in the presence of hydrophobins.
- One preferred embodiment of the present invention comprises a crystallization of solids from liquid phases. The liquid phases comprise one or more solvents, dissolved solid and/or starting materials for their production, the hydrophobins and also optionally further components, for example further auxiliary materials. The choice of solvent or solvent mixture is not restricted in principle, provided the solids to be crystallized and the hydrophobins have sufficient solubility therein. A person skilled in the art will make suitable choice depending on the solid to be crystallized.
- The liquid phases preferably comprise aqueous phases. The term “aqueous phase” is to be understood as meaning that the solvents used comprise at least 50% by weight of water, based on the total amount of all solvents used. The water content is preferably at least 70% by weight and more preferably at least 90% by weight. Possible cosolvents include water-miscible solvents, for example alcohols such as methanol, ethanol or propanol. It is very particularly preferred for the solvent to comprise exclusively water.
- The pH of the aqueous phase can be chosen by one skilled in the art according to the identity of the solid to be crystallized and according to the properties desired for the solid. According to the present invention, the hydrophobins, preferably fusion hydrophobins can advantageously be used at a pH≧4, in particular 4 to 13. The pH range is preferably from 5 to 13, more preferably from 6 to 12 and most preferably from 7 to 11.
- The amount of the hydrophobins to be used can be chosen by one skilled in the art according to the identity of the solid to be crystallized and according to the properties desired for the solid. In general an amount of less than 1% by weight based on the sum total of all the constituents of the aqueous phase will be found advantageous. The hydrophobins may preferably be used in an amount of 0.001% by weight to 1% by weight, more preferably 0.001% to 0.2% by weight.
- All manner of crystallization processes from liquid phases are possible in principle. One possibility for example is a crystallization process wherein a saturated solution of the solid is used and the crystallization of the solid is induced by evaporating the solvent, cooling or admixing a further solvent in which the solid is not soluble. Another possibility is a reactive precipitation wherein the solid is only formed in the aqueous phase as a result of the reaction of soluble components with each other.
- One particularly preferred embodiment of the present invention utilizes the abovementioned fusion hydrophobins. For example, yaad-Xa-dewA-his (SEQ ID NO: 20) can be used and also, in particular, proteins having a truncated yaad residue, for example yaad40-Xa-dewA-his. It is advantageous to use the products obtained by the simplified purification process described above.
- The hydrophobins are useful as auxiliaries for crystallizing both inorganic and organic solids from liquid phases. The hydrophobins are particularly useful as auxiliaries for crystallizing gypsum (CaSO4*2H2O). instead of acicular crystallites, more compact crystallites having a distinctly smaller length/thickness ratio are obtained which are easier to separate from the aqueous phase.
- The hydrophobins are further very useful for crystallizing calcium carbonate.
- In one preferred embodiment of the present invention, the hydrophobins can be used in a process for producing solids by crystallizing from an aqueous phase and removing the solid formed from the aqueous phase. The process in question may particularly preferably be a process for removal of gypsum.
- The step of crystallizing and preferred conditions were described above. The solids, preferably the gypsum, can be removed by methods known to one skilled in the art, for example by filtration or by a combination of various measures to separate liquids from solids. After separation, the moist solid can be dried and further processed.
- The process of the present invention may particularly comprise a step of a flue gas desulfurization process. In a flue gas desulfurization process, a first stage comprises gaseous SO2 present in the flue gas being reacted in a washers known to one skilled in the art with an aqueous CaCO3 suspension to form CaSO3 which is oxidized with O2 to form CaSO4, which crystallizes out as CaSO4*2H2O. Thus, gypsum is formed continuously in the aqueous phase by reaction. To control the crystal form, the hydrophobins are added to the process water in the above-stated concentrations.
- Flue gas desulfurization processes are known to those skilled in the art. The reaction of SO2 and CaCO3 may be carried out coutercurrently for example. The gypsum crystals formed can initially be separated off, as a concentrated gypsum suspension, in a hydrocyclone and then be recovered as a solid by filtration, washing and drying. For further details reference may be made to “Calcium Sulfate—3.2 Flue Gas Desulphokation (FOG) Gypsum” in Ullmann's Encyclopedia of Industrial Chemistry, 7th Edition 2006, Electronic Release, Wiley-VCH, Weinheim, New York 2006, and also the references cited therein. The gypsum formed can subsequently be burned (anhydride) and be used for example in a known manner in the building materials industry.
- The examples which follow illustrate the invention:
- The examples utilized a fusion hydrophobin with the complete fusion partner yaad (yaad-Xa-dewA-his; hereinafter referred to as hydrophobin A) and also a fusion hydrophobin having a fusion partner truncated to 40 amino acids, yaad40-Xa-dewA-his (hydrophobin B). They were prepared as per the procedure described in WO 2006/082253.
- The products were worked up by the simplified purification process of Example 9 of WO 2006/82253 and spray dried according to Example 10 of the same reference. The total protein content of the dried products obtained was in each case about 70% to 95% by weight, and the hydrophobin content was about 40% to 90% by weight based on the total protein content. The products were used as such for the experiments.
- glass (window glass, Süddeutsche Glas, Mannheim)
- For the tests, the spray-dried products comprising fusion hydrophobins were dissolved in water in the presence of 50 mm sodium acetate pH 4 and 0.1% by weight of polyoxyethylene(20) sorbitan monolaurate (Tween® 20). Concentration of product: 100 μg/mL in aqueous solution.
-
-
- incubation of glass slides overnight (temperature 80° C.), then coating wash in distilled water,
- thereafter incubation 10 min/80° C./1% sodium dodecylsulfate (SDS) solution in distilled water,
- washing in distilled water
- The samples are air dried and subjected at room temperature to a determination of the contact angle (in degrees) of a droplet of 5 μl of water.
- The contact angle measurement was determined on a Dataphysics Contact Angle System OCA 15+, Software SCA 20.2.0. (November 2002). The measurement was carried out in accordance with the manufacturer's instructions.
- Untreated glass gave a contact angle of 15° to 30°±5°. A coating with the fusion hydrophobin yaad-Xa-dewA-his6 gave a contact angle increase of more than 30°; a coating with the fusion hydrophobin yaad40-Xa-dewA-his likewise gave a contact angle increase of more then 30°.
- Tests for crystallization of gypsum
- A saturated solution of CaSO4×2H2 in completely ion-free water was prepared (concentration about 2 g/l). The solutions were each admixed with hydrophobin A and hydrophobin B respectively, so that the gypsum solution had a concentration of about 0.1 g/l of the spray-dried product. The pH of the solution was adjusted with HCl and NaOH respectively. The aqueous solutions/dispersions were filtered through a pleated filter (about 10 μm). Thereafter, about 25 ml of each solution were transferred into a Petri dish and the water was allowed to evaporate at room temperature in the course of about 24 hours. A solution was left for comparison without added hydrophobin.
- The forms of the gypsum crystals formed were compared with a BH-2 microscope from Olympus.
FIGS. 1 to 6 each show micrographs of the crystals obtained (40 fold magnification, particle size in each case about 0.01-0.1 mm). -
FIG. 1 pH 8, no addition of hydrophobin -
FIG. 2 pH 8, addition of hydrophobin A -
FIG. 3 pH 8, addition of hydrophobin B -
FIG. 4 pH 4, addition of hydrophobin B -
FIG. 5 pH 6, addition of hydrophobin B -
FIG. 6 pH 10, addition of hydrophobin B -
FIGS. 1 to 6 show that the crystal form of gypsum can be influenced via hydrophobins. Gypsum precipitated at pH 8 without auxiliary consists of needles having a length/thickness ratio of about 10 (FIG. 1 ). Gypsum precipitated at a pH of 8 with addition of hydrophobin A (FIG. 2 ) or hydrophobin B (FIG. 3 ) no longer consists of needles; instead, relatively compact prisms having a length/thickness ratio of about 2 to 3 are obtained. The needle length is distinctly truncated compared with the test without added hydrophobin. Such compact particles have better filtration properties. - The needle length is truncated by the hydrophobins at all pH values (
FIGS. 4 to 6 ). This effect is most pronounced in the alkaline pH region (FIGS. 1 to 3 and 6), in which prisms are obtained almost exclusively and no longer any needles.
Claims (15)
1-8. (canceled)
9. A process for producing a solid, the process comprising the steps of crystallizing the solid from an aqueous phase by adding an auxiliary in an amount of 0.001% to 1% by weight based on the total amount of the aqueous phase, and separating the solid from the aqueous phase, wherein the auxiliary comprises a hydrophobin.
10. The process of claim 9 wherein the pH of the aqueous phase is about pH 7 to about pH 11.
11. The process of claim 9 wherein the solid comprises gypsum.
12. The process of claim 9 wherein the solid comprises calcium carbonate.
13. The process of claim 9 wherein the solid comprises a compound selected from the group consisting of gypsum and calcium carbonate, and wherein the process further comprises a flue gas desulfurization process.
14. The process of claim 9 wherein the hydrophobin comprises a hydrophobin fusion.
15. A method for crystallizing a solid wherein a hydrophobin is incorporated as an auxiliary soluble.
16. The method of claim 15 wherein the solid is crystallized from a liquid phase.
17. The method of claim 16 wherein the hydrophobin comprises 0.001% to 1% by weight based on the total amount of the liquid phase.
18. The method of claim 15 wherein the liquid phase comprises an aqueous phase.
19. The method of claim 18 wherein the pH of the aqueous phase is about pH 7 to about pH 11.
20. The method of claim 18 wherein the solid comprises gypsum.
21. The method of claim 18 wherein the solid comprises calcium carbonate.
22. The method of claim 15 wherein the hydrophobin comprises a hydrophobin fusion.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07108856.1 | 2007-05-24 | ||
EP07108856 | 2007-05-24 | ||
PCT/EP2008/056263 WO2008142111A1 (en) | 2007-05-24 | 2008-05-21 | Use of hydrophobins as additives in the crystallization of solids |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100166627A1 true US20100166627A1 (en) | 2010-07-01 |
Family
ID=39684302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/601,281 Abandoned US20100166627A1 (en) | 2007-05-24 | 2008-05-21 | Use of hydrophobins as additives in the crystallization of solids |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100166627A1 (en) |
EP (1) | EP2155611A1 (en) |
JP (1) | JP2010527886A (en) |
KR (1) | KR20100022482A (en) |
CN (1) | CN101679063A (en) |
CA (1) | CA2687490A1 (en) |
CL (1) | CL2008001513A1 (en) |
MX (1) | MX2009012309A (en) |
RU (1) | RU2009147812A (en) |
TW (1) | TW200914378A (en) |
WO (1) | WO2008142111A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090041922A1 (en) * | 2005-07-14 | 2009-02-12 | Basf Aktiengesellschaft | Aqueous monomer emulsions containing hydrophobin |
US20090233110A1 (en) * | 2005-03-31 | 2009-09-17 | Basf Aktiengeselischaft | Use of polypeptides in the form of adhesive agents |
US20110159050A1 (en) * | 2008-07-11 | 2011-06-30 | Basf Se | Amphiphilic proteins as morphology modifiers |
US20110218266A1 (en) * | 2008-11-03 | 2011-09-08 | Basf Se | Photoinitiator mixtures |
US8226967B2 (en) | 2008-11-27 | 2012-07-24 | Basf Se | Surface active proteins as excipients in solid pharmaceutical formulations |
WO2012142557A1 (en) * | 2011-04-15 | 2012-10-18 | Danisco Us Inc. | Methods of purifying hydrophobin |
US8758730B2 (en) | 2009-02-26 | 2014-06-24 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011015530A2 (en) | 2009-08-03 | 2011-02-10 | Basf Se | Process for deposition of thin layers of metal oxides |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4183908A (en) * | 1977-06-24 | 1980-01-15 | Southern California Edison Company | Crystalline calcium sulfate dihydrate and process for making same |
US5246677A (en) * | 1991-05-07 | 1993-09-21 | Electric Power Research Institute | Addition of organophosphonates for size control of wet calcium-based FGD byproduct solids under forced oxidation conditions |
US20060040349A1 (en) * | 2004-08-18 | 2006-02-23 | Sweigard James A | Thermophilic hydrophobin proteins and applications for surface modification |
US20080319168A1 (en) * | 2005-02-07 | 2008-12-25 | Basf Aktiengesellschaft | Method for Coating Surfaces with Hydrophobins |
US20090104663A1 (en) * | 2005-02-07 | 2009-04-23 | Basf Aktiengesellschaft | Novel Hydrophobin Fusion Products, Production and Use Thereof |
US20090101167A1 (en) * | 2005-08-01 | 2009-04-23 | Basf Aktiengesellschaft | Use of Surface-Active Non-Enzymatic Proteins for Washing Textiles |
US20090131281A1 (en) * | 2005-04-01 | 2009-05-21 | Marcus Guzmann | Drilling Fluid containing hydrophobin |
US20090136996A1 (en) * | 2005-06-10 | 2009-05-28 | Basf Aktiengesellschaft | Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB562561A (en) * | 1942-12-17 | 1944-07-06 | Cuthbert Leslie Haddon | Improvements in the manufacture of plaster of paris |
JPS5532789A (en) * | 1979-08-14 | 1980-03-07 | Hiyougoken | Production of hexagonal prismatic crystal alpha-type hemihydrate gypsum |
DE3522494A1 (en) * | 1985-06-24 | 1987-01-02 | Heinrich Quante | Process for controlling crystallization from solutions and apparatus for carrying out the process |
KR101250067B1 (en) * | 2005-03-30 | 2013-04-03 | 바스프 에스이 | Use of hydrophobin for hard surface soil-repellent treatment |
MX2007011125A (en) * | 2005-04-01 | 2007-10-23 | Basf Ag | Use of proteins as demulsifying agents. |
DE102005025969A1 (en) * | 2005-06-03 | 2006-12-28 | Basf Ag | Reduction of evaporation rate of water in an open water reservoir, comprises mixing of hydrophobin fusion protein with water and/or biodegradable barrier liquid having hydrocarbon mixture |
-
2008
- 2008-05-21 KR KR1020097026772A patent/KR20100022482A/en not_active Application Discontinuation
- 2008-05-21 JP JP2010508843A patent/JP2010527886A/en not_active Withdrawn
- 2008-05-21 US US12/601,281 patent/US20100166627A1/en not_active Abandoned
- 2008-05-21 EP EP08759865A patent/EP2155611A1/en not_active Withdrawn
- 2008-05-21 MX MX2009012309A patent/MX2009012309A/en unknown
- 2008-05-21 CA CA002687490A patent/CA2687490A1/en not_active Abandoned
- 2008-05-21 CN CN200880017298A patent/CN101679063A/en active Pending
- 2008-05-21 RU RU2009147812/05A patent/RU2009147812A/en not_active Application Discontinuation
- 2008-05-21 WO PCT/EP2008/056263 patent/WO2008142111A1/en active Application Filing
- 2008-05-22 TW TW097118950A patent/TW200914378A/en unknown
- 2008-05-23 CL CL2008001513A patent/CL2008001513A1/en unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4183908A (en) * | 1977-06-24 | 1980-01-15 | Southern California Edison Company | Crystalline calcium sulfate dihydrate and process for making same |
US5246677A (en) * | 1991-05-07 | 1993-09-21 | Electric Power Research Institute | Addition of organophosphonates for size control of wet calcium-based FGD byproduct solids under forced oxidation conditions |
US20060040349A1 (en) * | 2004-08-18 | 2006-02-23 | Sweigard James A | Thermophilic hydrophobin proteins and applications for surface modification |
US20080319168A1 (en) * | 2005-02-07 | 2008-12-25 | Basf Aktiengesellschaft | Method for Coating Surfaces with Hydrophobins |
US20090104663A1 (en) * | 2005-02-07 | 2009-04-23 | Basf Aktiengesellschaft | Novel Hydrophobin Fusion Products, Production and Use Thereof |
US20090131281A1 (en) * | 2005-04-01 | 2009-05-21 | Marcus Guzmann | Drilling Fluid containing hydrophobin |
US20090136996A1 (en) * | 2005-06-10 | 2009-05-28 | Basf Aktiengesellschaft | Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
US20090101167A1 (en) * | 2005-08-01 | 2009-04-23 | Basf Aktiengesellschaft | Use of Surface-Active Non-Enzymatic Proteins for Washing Textiles |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090233110A1 (en) * | 2005-03-31 | 2009-09-17 | Basf Aktiengeselischaft | Use of polypeptides in the form of adhesive agents |
US8859106B2 (en) | 2005-03-31 | 2014-10-14 | Basf Se | Use of polypeptides in the form of adhesive agents |
US20090041922A1 (en) * | 2005-07-14 | 2009-02-12 | Basf Aktiengesellschaft | Aqueous monomer emulsions containing hydrophobin |
US20110159050A1 (en) * | 2008-07-11 | 2011-06-30 | Basf Se | Amphiphilic proteins as morphology modifiers |
US20110218266A1 (en) * | 2008-11-03 | 2011-09-08 | Basf Se | Photoinitiator mixtures |
US8507726B2 (en) | 2008-11-03 | 2013-08-13 | Basf Se | Photoinitiator mixtures |
US8226967B2 (en) | 2008-11-27 | 2012-07-24 | Basf Se | Surface active proteins as excipients in solid pharmaceutical formulations |
US8758730B2 (en) | 2009-02-26 | 2014-06-24 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
WO2012142557A1 (en) * | 2011-04-15 | 2012-10-18 | Danisco Us Inc. | Methods of purifying hydrophobin |
Also Published As
Publication number | Publication date |
---|---|
CL2008001513A1 (en) | 2009-10-23 |
KR20100022482A (en) | 2010-03-02 |
WO2008142111A1 (en) | 2008-11-27 |
MX2009012309A (en) | 2009-12-01 |
RU2009147812A (en) | 2011-06-27 |
JP2010527886A (en) | 2010-08-19 |
CN101679063A (en) | 2010-03-24 |
TW200914378A (en) | 2009-04-01 |
EP2155611A1 (en) | 2010-02-24 |
CA2687490A1 (en) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100166627A1 (en) | Use of hydrophobins as additives in the crystallization of solids | |
RU2275377C2 (en) | Method for space packing chemically synthesized polypeptides | |
TW201639867A (en) | Peptide synthesis method | |
CA2790186C (en) | Separation of insoluble target proteins | |
EP1735345A2 (en) | Processes for preparing eptifibatide and pertinent intermediate compounds | |
Ikeuchi et al. | Behavior of the 36,000-dalton protein in the internal membranes of squash etioplasts during greening | |
EP0759933B1 (en) | Beta sheet forming peptides and gels made thereof | |
Wu et al. | Nanofiltration recovery of sericin from silk processing waste and synthesis of a lauroyl sericin-based surfactant and its characteristics | |
JP2012519767A (en) | Use of a synergistic mixture of water-soluble polymer and hydrophobin for thickening aqueous phase | |
CN110294793B (en) | SUMO fluorescent probe and preparation method thereof | |
EP1756141B1 (en) | Process for the preparation of peptides | |
Niidome et al. | Membrane interaction of synthetic peptides related to the putative fusogenic region of PH‐30α, a protein in sperm‐egg fusion | |
Patthy | A family of laminin-related proteins controlling ectodermal differentiation in Drosophila | |
Hamada et al. | Conformational changes of α-lactalbumin and its fragment, Phe 31-Ile 59, induced by sodium dodecyl sulfate | |
AU2008240334B2 (en) | Process for extracting hydrocarbons from oil sand | |
CN102124022A (en) | Use of a tpb salt for the separation of biomolecules | |
Niu et al. | Preparing bioactive surface of polystyrene with hydrophobin for trypsin immobilization | |
US20120202068A1 (en) | Process for deposition of thin layers of metal oxides | |
US6841658B2 (en) | Purification of human Troponin I | |
WO2013057736A2 (en) | Preparation of eptifibatide peptide | |
Chakrabarti et al. | Purification and characterization of a low molecular weight basic protein from marine turtle egg white | |
Ambroggio et al. | Biophysical properties of a synthetic transit peptide from wheat chloroplast ribulose 1, 5‐bisphosphate carboxylase | |
US20030105017A1 (en) | Purification of human Troponin I | |
Arellano et al. | Interaction of protamine fragments with DNA | |
JPWO2005056589A1 (en) | Peptide in which self-assembly is induced at a specific salt concentration and its self-assembly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BASF SE,GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BAUS, ULF;MONTAG, THORSTEN;BECKER, STEFAN;AND OTHERS;SIGNING DATES FROM 20080530 TO 20080620;REEL/FRAME:023553/0958 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |